Viewing Study NCT01803035


Ignite Creation Date: 2025-12-24 @ 10:38 PM
Ignite Modification Date: 2026-01-02 @ 6:24 AM
Study NCT ID: NCT01803035
Status: COMPLETED
Last Update Posted: 2014-04-28
First Post: 2013-02-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Study to Evaluate the Efficacy and Safety of Two Doses of LTX-109 in Impetigo
Sponsor: Lytix Biopharma AS
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module